- WHO publishes a new guideline for hepatitis B
- Hepatitis C antiviral drug stock-out occurs again in Indonesia
- ITPC’S MISSING THE TARGET EXPOSES IMPACT OF COVID -19 ON HIV TREATMENT ACCESS COSTS IN BRAZIL, INDONESIA, UGANDA, USA AND OTHER COUNTRIES.
- National Hepatitis Elimination Profile : Indonesia
- HIV/AIDS and Sexually Transmitted Disease Progress Report-Quarter II, 2022
- HIV/AIDS and Sexually Transmitted Disease Progress Report-Quarter I, 2022
- HIV/AIDS and Sexually Transmitted Disease Progress Report-Quarter IV, 2021
- National Guidelines for Medical Management of Liver Cancer in Adults (August 2022)
- HIV/AIDS and Sexually Transmitted Disease Progress Report-Quarter III, 2021
- Beware of acute hepatitis in children
- WHO Publishes Covid-19 Self-Test Guide
- List of COVID-19 Testing Network Laboratories
- Update: Highest tariff for Rapid Antigen Covid-19 tests
- Hepatitis B Tests on Labor Medical Examination
- ITPC assessing report : the impact of Covid-19 on PLHIV
- Assessing the impact of COVID-19 on access to health services for key populations and people living with HIV in Indonesia
- Current RT-PCR test fee – August 2021
- WHO Guideline recommendation from a research including Peduli Hati Bangsa
- National Guidance for Hepatitis C Services
- Covid-19 control during Ramadhan month
- Annual Report 2020
- Hepatitis Handbook 2020
- Jakarta Lockdown Guidelines
- Hepatitis B and Hepatitis C Training Module
- Indonesia Official nCoV Guidelines for Preparedness Guidelines
- Ministerial Decree about Covid-19 Prevention and Control Guideline
- HIV/AIDS Service Protocol during Covid-19 outbreak
- B-4 Protocol : Practical Guidance for Mother and Infant Health during Covid-19 period
Yayasan Peduli Hati BangsaYayasan Peduli Hati Bangsa